EVALUATION OF BREAST CANCER RISK FACTORS FOR USING IN HORMONE REPLACEMENT THERAPY OF CORTICOSTEROIDTREATED POST-MENOPAUSAL WOMEN

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

PESSARAN Z.; REZAEI A.; SIADAT A.H.; TAVAKOLIKIA R.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Journal of Shahrekord University of Medical Sciences Year:2003 | Volume:5 | Issue:2 Page(s): 70-75

Download Full-Text

Persian Verion

View:

1,113

Download:

Cites:

Information Journal Paper

Title

EVALUATION OF BREAST CANCER RISK FACTORS FOR USING IN HORMONE REPLACEMENT THERAPY OF CORTICOSTEROIDTREATED POST-MENOPAUSAL WOMEN

Author(s)

PESSARAN Z. | REZAEI A. | SIADAT A.H. | TAVAKOLIKIA R. | Issue Writer Certificate

Keywords

BREAST CANCERQ2

RISK FACTORSQ4

HORMONE REPLACEMENT THERAPYQ3

CORTICOSTEROIDQ3

POST-MENOPAUSAL WOMENQ3

Abstract

Systemic CORTICOSTEROIDs are the essential part of treatment in many coetaneous autoimmune diseases. Osteoporosis and other side effects could be seen during treatment with these drugs, especially in postmenopausal women. HORMONE REPLACEMENT THERAPY (HRT) has been recommended to prevent and reduce the complications in these patients. On the other hand, this kind of prophylaxy may increase the risk of the BREAST CANCER. In this study, the RISK FACTORS of the BREAST CANCER were evaluated to make a guideline for using HRT in postmenopausal women. This retrospective survey was performed on randomly selected samples of 176 normal people and 176 patients suffering from BREAST CANCER. Data was collected by questionnaires and interviews. The RISK FACTORS of BREAST CANCER, in order of importance, are followings: family history, delayed menopause, delay in first pregnancy, short duration of breast feeding, having less than 2 children and nuliparity. There was no significant relation between history of abortion or age of the first menstruation and BREAST CANCER.Regarding the results, it is recommended that HRT should not be done in patients with positive family history of BREAST CANCER and could be done with caution in patients with delayed menopause, delay in the first pregnancy, short duration of breast feeding, less than 2 children and nuliparity.

Cites

No record.

References

No record.

Cite

APA: Copy

PESSARAN, Z., REZAEI, A., SIADAT, A.H., & TAVAKOLIKIA, R.. (2003). EVALUATION OF BREAST CANCER RISK FACTORS FOR USING IN HORMONE REPLACEMENT THERAPY OF CORTICOSTEROIDTREATED POST-MENOPAUSAL WOMEN. JOURNAL OF SHAHREKORD UNIVERSITY OF MEDICAL SCIENCES, 5(2), 70-75. SID. https://sid.ir/paper/58910/en

Vancouver: Copy

PESSARAN Z., REZAEI A., SIADAT A.H., TAVAKOLIKIA R.. EVALUATION OF BREAST CANCER RISK FACTORS FOR USING IN HORMONE REPLACEMENT THERAPY OF CORTICOSTEROIDTREATED POST-MENOPAUSAL WOMEN. JOURNAL OF SHAHREKORD UNIVERSITY OF MEDICAL SCIENCES[Internet]. 2003;5(2):70-75. Available from: https://sid.ir/paper/58910/en

IEEE: Copy

Z. PESSARAN, A. REZAEI, A.H. SIADAT, and R. TAVAKOLIKIA, “EVALUATION OF BREAST CANCER RISK FACTORS FOR USING IN HORMONE REPLACEMENT THERAPY OF CORTICOSTEROIDTREATED POST-MENOPAUSAL WOMEN,” JOURNAL OF SHAHREKORD UNIVERSITY OF MEDICAL SCIENCES, vol. 5, no. 2, pp. 70–75, 2003, [Online]. Available: https://sid.ir/paper/58910/en

Related Journal Papers